Artivion’s Commitment to Investor Engagement
Artivion, Inc. (NYSE: AORT), a prominent name in the cardiac and vascular surgery sector, is poised to make significant waves as it prepares to participate in two upcoming investor conferences. These conferences represent not just opportunities for the company to share its innovative approaches to aortic disease but also a chance to engage actively with potential investors and stakeholders.
Stifel Healthcare Conference Participation
The management team of Artivion is scheduled to present at the Stifel 2024 Healthcare Conference. This prestigious event will take place at the iconic Lotte New York Palace hotel. Artivion's presentation is set to kick off at 1:15 p.m. ET on the specified day, offering insights into the company's strategic direction and product offerings aimed at revolutionizing treatment options for patients with aortic diseases. A live webcast will be available on Artivion’s website, ensuring real-time access for interested parties who wish to learn more about their innovative solutions.
Webcast Accessibility
For those unable to attend the live presentation, Artivion assures that an archived version of the webcast will be accessible for a duration of 90 days on their website. This feature underscores Artivion’s commitment to transparency and communication with its stakeholders.
One-on-One Meetings at the Canaccord Genuity Forum
In addition to the Stifel conference, Artivion’s management will also be engaging in one-on-one meetings at the upcoming Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum. Unlike the Stifel presentation, this event will focus on more personalized discussions, providing an intimate setting for investors to ask questions and gain deeper insights into the company’s operations and future prospects. However, attendees should note that there will be no webcast available for this forum due to its unique format.
Artivion’s Product Innovations
Artivion has consistently focused on developing advanced medical devices that address the pressing challenges faced by cardiac and vascular surgeons in treating aortic diseases. The company's product range includes aortic stent grafts, On-X mechanical heart valves, and surgical sealants. Each of these innovations reflects Artivion's dedication to providing elegant and effective solutions, improving patient outcomes across diverse settings.
About Artivion, Inc.
Headquartered in suburban Atlanta, Artivion sits at the forefront of medical device innovation, catering to the needs of surgeons worldwide. The company operates in numerous countries, highlighting its international reach and commitment to improving healthcare outcomes. Their approach is centered around understanding the intricate needs of cardiac and vascular professionals, allowing them to develop products that truly make a difference.
Global Reach and Market Presence
Artivion’s global footprint allows them to impact a broad variety of markets, tailoring their products to meet regional needs while adhering to the highest quality standards. This global approach is crucial, especially in the rapidly evolving field of medical technology.
Frequently Asked Questions
What is the focus of the upcoming Stifel Healthcare Conference?
The conference will focus on Artivion’s innovations and strategies in treating aortic diseases, showcasing their latest products and technologies.
Where can I access the recorded presentation from the event?
Artivion will archive the webcast on their website, allowing viewers to access it for 90 days following the live event.
What are Artivion's main product offerings?
Artivion specializes in aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular tissues.
How can I contact Artivion for further information?
For more details, you can contact Artivion directly through their customer service or corporate communications channels for inquiries.
When will the Canaccord Genuity Forum take place?
The event is set to occur shortly after the Stifel Healthcare Conference, featuring one-on-one meetings with the management team.
